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Abstract
Background: Globally, postpartum haemorrhage (PPH) remains a leading cause of maternal deaths. However in
many low and middle income countries, there is scarcity of information on magnitude of and risk factors for PPH
(blood loss of 500 ml or more). It is important to understand the relative contributions of different risk factors for
PPH. We assessed the incidence of, and risk factors for postpartum hemorrhage among rural women in Uganda.
Methods: Between March 2013 and March 2014, a prospective cohort study was conducted at six health facilities
in Uganda. Women were administered a questionnaire to ascertain risk factors for postpartum hemorrhage, defined
as a blood loss of 500 mls or more, and assessed using a calibrated under-buttocks drape at childbirth. We constructed
two separate multivariable logistic regression models for the variables associated with PPH. Model 1 included all
deliveries (vaginal and cesarean sections). Model 2 analysis was restricted to vaginal deliveries. In both models, we
adjusted for clustering at facility level.
Results: Among the 1188 women, the overall incidence of postpartum hemorrhage was 9.0 %, (95 % confidence
interval [CI]: 7.5–10.6 %) and of severe postpartum hemorrhage (1000 mls or more) was 1.2 %, (95 % CI 0.6–2.0 %). Most
(1157 [97.4 %]) women received a uterotonic after childbirth for postpartum hemorrhage prophylaxis. Risk factors for
postpartum hemorrhage among all deliveries (model 1) were: cesarean section delivery (adjusted odds ratio
[aOR] 7.54; 95 % CI 4.11–13.81); multiple pregnancy (aOR 2.26; 95 % CI 0.58–8.79); foetal macrosomia ≥4000 g
(aOR 2.18; 95 % CI 1.11–4.29); and HIV positive sero-status (aOR 1.93; 95 % CI 1.06–3.50). Risk factors among
vaginal deliveries only, were similar in direction and magnitude as in model 1, namely: multiple pregnancy,
(aOR 7.66; 95 % CI 1.81–32.34); macrosomia, (aOR 2.14; 95 % CI1.02–4.47); and HIV positive sero-status
(aOR 2.26; 95 % CI 1.20–4.25).
Conclusion: The incidence of postpartum hemorrhage was high in our setting despite use of uterotonics.
The risk factors identified could be addressed by extra vigilance during labour and preparedness for PPH
management in all women giving birth.
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Background
Globally, postpartum hemorrhage (PPH) is a leading
cause of maternal mortality [1]. The global prevalence of
PPH is 6 % [2] and the highest burden is experienced in
low-income countries [3, 4]. The magnitude of PPH in
sub-Saharan Africa is high at 10.5 % [2]. In Uganda,
PPH causes 25 % of all maternal deaths [5]. However,
there is little information on the magnitude and risk fac-
tors for PPH. Common causes of PPH are uterine atony,
genital tract injuries, failure of the blood coagulation sys-
tem and trauma. Uterine atony is responsible for the
majority (75 %) of PPH [6]. Risk factors for PPH include;
past history of PPH, multiple pregnancy, fetal macroso-
mia, primi-gravida, grand multi-parity, older age, pre-
term births, genital tract injuries, non-use of oxytocics
for PPH prophylaxis, labour induction, cesarean birth
and intra-uterine fetal deaths [4, 7–10]. However, major-
ity of these studies visually estimated blood loss, a
method that has considerable inaccuracy [11]. The few
studies that have objectively measured blood loss after
childbirth are in high-income countries, whose delivery
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settings differ from those in low income countries [12].
This study used a calibrated under-buttocks drape to
measure blood loss that is highly correlated with the gold-
standard measure of photospectometry [13]. Knowledge
of the risk factors would inform public health interven-
tions for PPH control. To the clinicians, risk factor identi-
fication in the antenatal and intrapartum periods may
provide an opportunity for timely interventions to prevent
PPH. The present study was undertaken to objectively as-
sess the incidence and risk factors for PPH among women
in rural health facilities in Uganda.
Methods
Uganda’s health system has 7 facility levels. As part of a
stepped-wedge cluster-randomized trial on prevention of
PPH using misoprostol (Registered in Pan African Clinical
Trials Network: PACTR201303000459148), a prospective
cohort study was conducted among women who delivered
at six lower level health facilities (5 health centre IIIs and
one health centre IV) in Mpigi district, Central Uganda
between 6th March 2013 and 19th March 2014 [14]. The
health centre IIIs, serve a sub-county with average popula-
tion of 25,000 people [15], and are staffed by clinical offi-
cers, nurses, midwives, laboratory technician, and a health
inspector. Maternity services offered at health centre III
are basic essential obstetric care. In addition, these health
facilities offer prevention of mother to child transmission
of Human Immune deficiency virus (HIV) services which
encompasses routine counseling and testing of all women
attending the antenatal clinic. Those found HIV positive
are routinely offered highly active anti-retroviral therapy
provided by government of Uganda [16]. Medical high risk
and complicated obstetric cases from health centre IIIs
are referred to either health centre IVs or to hospitals
(levels V–VII). Health centre IVs serve a health sub-
district with average population of 95,000. They are staffed
as for Health centre III with the addition of a medical offi-
cer(s) and an anaesthetic officer. Health centre IVs provide
comprehensive essential obstetric care, including caesar-
ean section [17]. The six health centers in the study were
purposively selected out of 9 eligible health facilities ac-
cording to the trial inclusion criteria. Ethical approval was
obtained from the School of Medicine Research and
Ethics Committee at Makerere University, Kampala,
Uganda, and the Uganda National Council for Science
and Technology. Informed written consent was obtained
from all participants at enrolment.
Data collection
Pregnant women were recruited at 28 weeks gestation or
greater. The trial included women who planned to stay
in the district during pregnancy, delivery and in the im-
mediate postpartum period. The study excluded women
who had a planned elective caesarean-section delivery or
who had previous caesarean-section scars. The partici-
pants who delivered at the six health facilities were
included in this study. Women who had missing data for
the primary outcome of blood loss (16.6 %) were
excluded in the analysis (Fig. 1). The health providers
in the delivery rooms in these health facilities were
trained on the data collection procedure and on
measurement of postpartum blood loss. During enrol-
ment, interviewer-administered questionnaires were
used to collect data on the risk factors including: previous
history of PPH, woman’s age in completed years, parity
and HIV sero-status obtained from patient records. Partic-
ipants’ hemoglobin levels were measured using a potable
hemoCueR Hb 301 system at recruitment. Gestational age
at birth was calculated based on ultrasound scan estima-
tion, the self-report of last normal menstrual period
(LNMP), or fundal height estimation. The research team
noted whether labour was induced or augmented with
oxytocin, the mode of delivery, performance of episiot-
omy, perineal tear requiring suture, single or multiple
deliveries, use of oxytocics at birth to prevent PPH (inject-
able oxytocin 10 IU or oral misoprostol 600 micrograms)
within 1 min of delivery. Birth weight was measured using
a Seca Medical 725 mechanical baby scale. The primary
outcome was postpartum hemorrhage defined as blood
loss of 500 mls or more after childbirth, while severe post-
partum hemorrhage was a blood loss of 1000 mls or more.
In women who had vaginal birth, postpartum blood loss
was measured using a calibrated under-buttocks V-
BRASSS drape [13]. After delivery of the baby and clamp-
ing of the umbilical cord, a drape was placed under the
woman’s buttocks. Blood was allowed to flow into the
drape for an hour or until the attending midwife felt that
the flow of blood is inconsequential. The total blood loss
collected in the calibrated conical receptacle was estab-
lished by the attending midwife. The used drapes with their
contents were disposed of correctly by the attending mid-
wife. In women who had cesarean section, we relied on the
visual estimation of blood loss by the operating clinician.
Statistical analysis
Data were double entered in Epidata 3.1, cleaned and
exported to STATA 12 for analysis. Descriptive statistics
provided the average blood loss and incidence of PPH.
The incidence of PPH in the first hour (immediate) post-
partum was calculated as total number of women with
blood loss of 500 ml or more, divided by the total study
sample and, was presented as a percentage. Characteris-
tics that were continuous and categorical variables were
calculated as means and proportions respectively. Bivari-
ate logistic regression analysis of the risk factors for PPH
was done to estimate crude odds ratios (cORs) and their
95 % confidence interval. We constructed two separate
multivariable logistic regression models for the variables
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associated with PPH. Model 1 included all deliveries
(vaginal and cesarean sections). Model 2 analysis was
restricted to only vaginal deliveries. Factors that had a p-
value less than 0.2 at bivariate analysis were entered into
multivariable logistic regression analysis to estimate the
adjusted odds ratios (aORs). In model 1, covariates ad-
justed for in multivariable logistic regression included
parity, maternal anaemia, past history of PPH, HIV sero-
status, mode of delivery, multiple pregnancy, macroso-
mia (4000 g or more) and perineal tears. In model 2,
mode of delivery was omitted. Because the participants
in the study were from 6 clusters (health facilities), we
adjusted for clustering in the logistic regression. A statis-
tical significance was defined as a p value <0.05.
We estimated that with prevalence of PPH of 6 %, .a
sample size of 1171 women would give a 90 % power to
detect a 40 % increased risk for PPH in grand-multiparous
women [2].
Results
Data collected among 1188 women showed mean blood
loss of 236 ml (±193 ml) and ranged from 50 to 1800
mls. Overall, 107 (9.0 %, 95 %; CI 7.5–10.6 %) women
had PPH and 14 (1.2 %, 95 %; CI 0.6–2.0 %) had severe
PPH (1000 mls or more). Table 1 shows the distribution
of socio-demographic, antepartum and intrapartum
characteristics of the study participants, and their associ-
ation with PPH. In general women with PPH tended to
be older, more likely to have twin births and HIV infec-
tion. They were also more likely to have delivered a
macrosomic baby, be postdates or have received no utero-
tonic. Overall, only 31 (2.6 %) women did not receive a
uterotonic at childbirth for PPH prevention. Main reasons
for not receiving uterotonic at birth were facility stock
outs of drugs and syringes. Among those who did receive
uterotonics, oxytocin was the most frequent drug admin-
istered. Out of the 82 (6.9 %) women who received add-
itional uterotonics at birth, majority (78) got misoprostol.
Women who had PPH were more than twice more likely
to have received additional uterotonic than those who did
not have PPH (14.0 % vs 6.2 %). The prevalence of PPH
and severe PPH among the 1113 women with vaginal de-
liveries were 7.4 % and 0.7 % respectively. Seven (0.6 %)
women received blood transfusion after childbirth, while 6
(0.5 %) were referred to hospital because of lack of blood
products at the study facility.
In model 1 that included both the vaginal and
cesarean deliveries Table 1, factors associated with
Deliveries N=2057
Delivered at home or TBA; 271
Delivered at private health 
facilities; 361
Delivered at the six health 
facilities n=1425
Excluded n=237    
Missing data for blood loss
Vaginal deliveries with measured 
blood loss n=1113
PPH n=82
Cesarean deliveries with measured  
blood loss n=75
PPH n=25
All deliveries with measured blood 
loss n=1188
Fig. 1 Profile of the study participants
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increased risk for PPH included: HIV sero positivity
(aOR 1.93; 95 % CI 1.06–3.50); cesarean section (aOR
7.54; 95 % CI 4.11–13.81); and fetal macrosomia
≥4000 g (aOR 2.18; 95 % CI 1.11–4.29). Multiple preg-
nancy and no uterotonic after childbirth, though signifi-
cant at unadjusted analysis, were not associated with
PPH after controlling for other risk factors. In the sec-
ond model (only vaginal deliveries) Table 2, factors asso-
ciated with increased risk for PPH at logistic regression
analysis included: HIV sero positivity (aOR 2.26; 95 % CI
1.20–4.25); multiple pregnancy (aOR 7.66; 95 % CI 1.81–
32.34); and fetal macrosomia ≥4000 g (aOR 2.14; 95 % CI
1.02–4.47). On the other hand, grand multi-parity was
marginally associated with PPH (p = 0.07).
All 14 (1.2 %) participants who developed severe PPH
received fluid replacement. Five women were given add-
itional oxytocin, two received blood transfusion and two
were transferred from health centre III to hospital; unfor-
tunately one died en-route. Of all participants who devel-
oped severe PPH, six were delivered by cesarean section,
and one was among those transfused. One woman had
cervical tear that was successfully repaired in theatre
under general anesthesia.
Discussion
This study demonstrated that, almost all (97 %) women
delivering at the six health facilities in rural Uganda re-
ceived a uterotonic for prevention of PPH. The overall
incidence of PPH was 9.0 % and of severe PPH was
1.2 %. The risk factors for PPH were being HIV positive,
multiple pregnancy, delivery by cesarean section and de-
livering a macrosomic baby. The study minimized classi-
fication bias of PPH by objectively measuring the blood
loss after child-birth using a calibrated drape.
The incidence of PPH in this study is higher than the
reported global rate of 6 % by Carroli et al [2], however
similar incidence of 10.8 % was reported by Calvert et al
[12]. This high incidence of PPH in this study may have
been influenced by the characteristics of the study popu-
lation; these were rural women that are reported to have
higher rates of PPH. Studies that have compared urban
and rural women have reported higher rates of PPH in
the later [2, 18]. The high rates in rural areas could be
related to substandard care. It is also possible that the
use of calibrated drape in assessment of postpartum
bleeding could have influenced the apparent high rate of
PPH since assessment of postpartum blood loss using a
calibrated drape is more objective way of determining
the rate of PPH. Most studies that report lower rates of
PPH have used visual estimation of blood loss [4] which
is known to underestimate the amount of measured
blood loss by 30 % [11]. Nevertheless since this study
found that the vast majority of women received oxyto-
cin, it is somewhat surprising that PPH was so high.
This raises concern about the cold chain maintenance
for the storage of oxytocin in rural settings where
Table 1 Association between the risk factors and postpartum hemorrhage among all deliveries
Variable No PPH (n = 1,081)a Had PPH (n = 107)a Crude OR (95 % CI) P value Adjusted OR (95 % CI) P value
Parity
Primiparous 301 (27.8) 31 (29.0) 0.97 (0.61–1.53) 0.47 0.85 (0.49–1.44) 0.30
2–4 545 (50.4) 58 (54.2) Reference Reference
5+ 235 (21.7) 18 (16.8) 0.72 (0.42–1.25) 0.64 (0.34–1.15)
Previous history of PPH 47 (4.4) 9 (8.4) 2.02 (0.96–4.24) 0.06 1.86 (0.81–4.26) 0.16
Gestation age at birth (weeks)
Preterm (<37) 181 (16.7) 16 (15.0) 0.90 (0.51–1.58) 0.76 0.80 (0.44–1.46) 0.71
Term (37–41) 762 (70.5) 75 (70.1) Reference Reference
Post term (>41) 138 (12.8) 16 (15.0) 1.18 (0.67–2.08) 1.07 (0.58–1.99)
Multiple pregnancy 10 (0.9) 4 (3.7) 4.16 (1.28–13.50) 0.02 2.26 (0.58–8.79) 0.26
Moderate-severe anemia in pregnancy 121 (11.2) 15 (14.0) 1.14 (0.85–1.52) 0.38 0.99 (0.72–1.35) 0.97
HIV positive 98 (9.1) 17 (15.9) 1.89 (1.08–3.31) 0.03 1.93 (1.06–3.50) 0.04
Cesarean-section birth 50 (4.6) 25 (23.4) 6.29 (3.70–10.68) <0.001 7.54 (4.11–13.81) <0.001
Labour induction/augmented 42 (3.9) 3 (2.8) 0.71 (0.22–2.34) 0.58
Macrosomia ≥4000gm 78(7.2) 15(14.0) 2.10(1.16–3.79) 0.01 2.25(1.14–4.43) 0.03
No uterotonic at birth 25 (2.3) 6 (5.6) 2.51(1.01–6.26) 0.05 2.23 (0.80–6.21) 0.14
Additional uterotonic 67 (6.2) 15 (14.0)
Episiotomy/Perineal tear 133 (12.3) 13 (12.1) 0.99 (0.54–1.81) 0.96 1.44 (0.71–2.94) 0.32
Abbreviation: PPH Postpartum hemorrhage, OR odds ratio, CI confidence interval, HIV Human Immunodeficiency Virus
a Values are given as numbers (percentages)
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electricity is not readily available. A national survey done
in 2007 on active management of the third stage of
labour found that 34.3 % of health facilities were storing
oxytocin at room temperature [19]. Using an alternative
uterotonic such as misoprostol that can be stored at
room temperature would be an option to consider in
setting with unstable electricity supply. However, we
noted that in our study, women getting misoprostol ver-
sus oxytocin for prophylaxis had a 36 % increased odds
of PPH. Delivery by cesarean section was associated with
increased risk of PPH. This is consistent with previous
studies that report cesarean births being associated with
increased risk of PPH [4, 6, 20]. However, few studies report
a protective effect of cesarean section against PPH when
compared to vaginal births [21, 22]. The lower rates of PPH
in cesarean section than in vaginal birth are in studies that
included participants not in labor. In our study, the
cesarean sections were performed in women who were in
labor and where the operative mode of delivery was decided
by attending physician for the good of the unborn baby and
woman, with some of the cesarean sections probably being
done late in advanced stages of labour. There is increased
risk of severe PPH when cesarean sections are performed
when the cervical dilatation is more than 9 cm or in second
stage of labor mainly due to avulsion of the blood vessels at
the delivery of impacted presenting part [23]. Our finding
support existing evidence showing that cesarean section
increases the risk of PPH [2, 4, 6, 20, 24]. Cesarean section
also increases risk of uterine atony, a leading cause of PPH
[6, 25]. Because women undergoing cesarean section are
at increased risk of PPH, health units performing them
should have blood bank capacity to respond to a need for
blood transfusion when required. In addition, its import-
ant for clinicians to re-assess the women destined for
emergency cesarean section when near or in second stage
of labour for possible instrumental vaginal (vacuum ex-
traction or forceps) delivery. These modes of delivery have
been observed to reduce the rates of cesarean section [26].
Table 2 Association between the risk factors and postpartum hemorrhage in vaginal deliveriesa
Variable No PPH n = 1,031 (%) PPH ≥500 mls n = 82 (%) Crude OR (95 % CI) P value Adjusted OR (95 % CI) P value
Age in years 0.89
≤19 199 (19.3) 17 (20.7) 1.11 (0.63–1.95)
20–34 754 (73.1) 58 (70.7) Ref
>34 78 (7.6) 7 (8.5) 1.17 (0.51–2.64)
Mean age (standard deviation) 24.5 (5.7) 24.4 (6.0) 0.93
Married 902 (87.5) 68 (82.9) 0.69 (0.38–1.27) 0.24
Grand multi-Parity 230 (22.3) 14 (17.1) 0.72 (0.40–1.30) 0.27 0.57 (0.31–1.08) 0.07
Past history of PPH 45 (4.4) 9 (11.0) 2.7 (1.27–5.74) 0.01 2.08 (0.89–4.85) 0.11
Gestational age at birth 0.82 0.84
Preterm (<37 weeks) 170 (16.5) 12 (14.6) 0.89 (0.47–1.69) 0.85 (0.43–1.67)
Term (37–41 weeks) 730 (70.8) 58 (70.7) Reference Reference
Post term (>41 weeks) 131 (12.7) 12 (14.6) 1.15 (0.60–2.21) 1.08 (0.54–2.16)
Multiple pregnancy 6 (0.6) 4 (4.9) 8.76 (2.42–31.7) 0.001 7.66 (1.81–32.34) 0.01
Anaemia in pregnancy 0.58 0.84
No anaemia 696 (67.5) 53 (64.6) Reference Reference
Mild anaemia 225 (21.8) 17 (20.7) 1.06 (0.64–1.75) 0.97 (0.58–1.62)
Moderate-severe anaemia 110 (10.7) 12 (14.6) 1.72 (0.65–4.57) 1.37 (0.47–3.98)
HIV positive 92 (8.9) 15 (18.3) 2.29 (1.25–4.16) 0.007 2.26 (1.20–4.25) 0.02
Macrosomia ≥4000 g 75 (7.3) 10 (12.2) 1.77 (0.88–3.57) 0.87 2.14 (1.02–4.47) 0.04
Uterotonic after birth 0.02 0.31
None 25 (2.4) 6 (7.3) 4.12 (1.22–13.8) 2.80 (0.75–10.4)
Oxytocin 903 (87.6) 70 (85.4) Reference Reference
Misoprostol 103 (10) 6 (7.3) 1.32 (0.56–3.13) 1.36 (0.56–3.27)
Additional uterotonic 67 (6.5) 14 (17.1) 2.96 (1.58–5.54) 0.001
Labor induced/ augmented
with oxytocin
37 (3.6) 1 (1.2) 0.33 (0.04–2.45) 0.28
Episiotomy/Perineal tear 131 (12.7) 13 (15.9) 1.29 (0.70–2.41) 0.42 1.44 (0.73–2.83) 0.29
Abbreviation: CI confidence interval, HIV Human Immunodeficiency Virus, PPH Postpartum hemorrhage, OR odds ratio; a Values are given as numbers (percentages)
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The risk of PPH was doubled in large (macrosomia,
≥4000 g) babies. The increased risk of PPH among
women giving birth to large babies has also been docu-
mented in previous studies [8, 9]. Large babies are
known to over-distend the uterus which is associated
with uterine atony. This findings call for more vigilance
on the part of practitioners attending labor and births to
identify women at risk, have adequate preparation and
plan for early intervention to prevent PPH. Multiple preg-
nancy was associated with increased risk of PPH. This is
consistent with previous studies that report multiple preg-
nancy being associated with PPH [6, 10, 20, 25, 27]. The
over distension caused by multiple pregnancy increases
the risk of uterine atony. In addition, the large placental
size in multiple increases the surface area for bleeding
after childbirth.
Our findings showed that HIV positive pregnant
women were more likely to have PPH than HIV nega-
tive, even in the analysis among vaginal births alone.
Though a review of literature show that there is no sig-
nificant difference in PPH rates between HIV positive
and negative women [28], one subsequent study showed
an increased risk of severe PPH among HIV positive
women [29]. While the mechanism through which HIV
causes PPH is not yet known, some have suggested that
the increased thrombocytopenia that is observed in
10–30 % of HIV positive persons might be the one re-
sponsible for hemorrhage [30, 31]. Alternatively, it has
been suggested that low level of care offered to HIV posi-
tive women at birth [28] could be responsible for the
increased risk, whereby the health providers might be
hesitant to implement an intervention when bleeding
starts for fear of exposing themselves especially when
there is no adequate protective gear. Our findings add to
the growing body of knowledge, highlighting the impact
of HIV on the health of women. This has clinical implica-
tions for the care of HIV positive pregnant in setting with
high prevalence of HIV. There is a need for more research
to further elucidate the problem and establish the mecha-
nisms whereby HIV may lead to PPH.
This study had the following limitations. First, the
findings are from health facilities and almost all women
received a uterotonic. It is known in Uganda that 48 %
of deliveries occur at home [32]. Thus, the findings may
not be generalizable to home deliveries. However, with
exception of one study site (Health Centre IV), the study
was conducted in lower level health facilities where ser-
vices like blood transfusion and surgery (cesarean sec-
tion) are not offered. Secondly, women who delivered by
cesarean section had blood measured by visual estima-
tion that has been known to underestimate blood loss.
However, these were 75 (6 %), and are unlikely to have
substantially affected the estimate of PPH risk. Thirdly
there were only 14 cases with severe PPH. The study
did not have adequate power to identify risk factors for
severe PPH.
Conclusion
The incidence of PPH was high despite many women
receiving uterotonic at delivery of the babies. The risk
factors for PPH in our setting were cesarean section,
multiple pregnancy, fetal macrosomia and HIV. Extra
vigilance during the antenatal and peripartum periods is
needed to identify women at risk and early intervention
to prevent PPH. It is important to remember that we
have to prepare for PPH in all women giving birth, as
some get PPH without any known risk factors.
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